News
The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.
Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
1d
MarketBeat on MSNHims' Weight Loss Expansion: Real Growth or Just Hype?CompanyOverview|NYSE:HIMS] One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made ...
Transcarent CEO Glen Tullman previously led Livongo, which was purchased by Teladoc in a 2020 agreement that valued the company at $18.5 billion.
Today CMS announced that payments to Medicare Advantage and Part D Prescription Plans would increase by 5.06% next year ...
Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...
Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results